Buscar
01/04/2025
Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis
Thaçi, D, Puig, L, Papp, K, Gold, LS, Fernández-Peñas, P, Huang, YH, Dossenbach, M, Falques, M, Agell, H, Schönherr, F, Vestergaard, C. Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025
Global Survey of Left Ventricular Assist Device (LVAD) Wean Protocols: A VAD Wean Registry Report
Ton, V, Najjar, E, Yehya, A, Bernhardt, A, Sokolski, M, Hrytsyna, Y, Knierim, J, Schlöglhofer, T, Caliskan, K, Zimpfer, D, Perez, SM, Kanwar, M, Patel, S, Potapov, E. Global Survey of Left Ventricular Assist Device (LVAD) Wean Protocols: A VAD Wean Registry Report. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2025; 44(4)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2025
Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR)
Jiménez-Blanco, M, Crespo-Leiro, MG, Carmena, MDGC, Bueno, MG, López-Vilella, R, Ortiz-Bautista, C, Farrero-Torres, M, Zegrí-Reiriz, I, Díaz-Molina, B, García-Romero, E, Rangel-Sousa, D, Salterain, N, Bravo, IG, Segovia-Cubero, J. Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR). JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2025; 44(4)DOI:10.1016/j.healun.2024.11.009. PMID:39577511. IF:6.000(Q1/1D).
01/04/2025
Development and external validation of a deep learning electrocardiogram model for risk stratification of coronary revascularization need in the emergency department
Krychtiuk, KA, Sionis, A. Development and external validation of a deep learning electrocardiogram model for risk stratification of coronary revascularization need in the emergency department. European Heart Journal-Acute Cardiovascular Care. 2025; 14(4)DOI:10.1093/ehjacc/zuaf058. PMID:40192550. IF:4.600(Q1/2D).
01/04/2025
Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock-CAT study
García-García, C, López-Sobrino, T, Sanz-Girgas, E, Cueto, MR, Aboal, J, Pastor, P, Buera, I, Sionis, A, Andrea, R, Rodríguez-López, J, Sánchez-Salado, JC, Tomas, C, Bañeras, J, Ariza, A, Lupón, J, Bayés-Genís, A, Rueda, F. Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock-CAT study. ESC Heart Failure. 2025; 12(2)DOI:10.1002/ehf2.15148. PMID:39587711. IF:3.700(Q1/3D).
01/04/2025
Early and late hospital readmissions after percutaneous left atrial appendage closure
Trinh, KH, Nuche, J, Cruz-González, I, Guedeney, P, Arzamendi, D, Freixa, X, Nombela-Franco, L, Peral, V, Caneiro-Queija, B, Mangieri, A, Trejo-Velasco, B, Asmarats, L, Cepas-Guillén, P, Salinas, P, Siquier-Padilla, J, Estevez-Loureiro, R, Laricchia, A, O'hara, G, Montalescot, G, Côté, M, Mesnier, J, Rodés-Cabau, J. Early and late hospital readmissions after percutaneous left atrial appendage closure. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(4)DOI:10.1016/j.rec.2024.07.009. PMID:39128822. IF:4.900(Q1/2D).
01/04/2025
Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop
Pearce, L, Galán-Arriola, C, Bell, RM, Carr, RD, Cunningham, J, Davidson, SM, Ghosh, AK, Giesz, S, Golforoush, P, Gourine, AV, Hermann, DM, Heusch, G, Ibanez, B, Kalkhoran, SB, Lecour, S, Lukhna, K, Ntsekhe, M, Sack, MN, Unwin, RJ, Vilahur, G, Walker, JM, Yellon, DM. Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop. BASIC RESEARCH IN CARDIOLOGY. 2025; 120(2)DOI:10.1007/s00395-024-01094-6. PMID:39681732. IF:8.000(Q1/1D).
01/04/2025
From mice to humans: advancing the path to cardioprotection
Badimon, L, Vilahur, G, Mendieta, G. From mice to humans: advancing the path to cardioprotection. CARDIOVASCULAR RESEARCH. 2025; 121(5)DOI:10.1093/cvr/cvaf048. PMID:40113589. IF:13.300(Q1/1D).